Cdc2 and cyclin B1 are commonly overexpressed in HCC patients and the overexpressions of these genes are positively associated with higher malignant status and poor prognosis of HCC patients [25], [26]. The gene discussed is CCNB1; the disease is hepatocellular carcinoma.